|
|
MIACALCIN® (calcitonin salmon) Nasal Spray Is Safe, Convenient, and Well-Tolerated by Many Patients
Those with GI problems
|
 | MIACALCIN Nasal Spray bypasses the digestive system |
|
| MIACALCIN Nasal Spray has no serious drug-related GI or esophageal side effects |
|
Those on multiple medications
|
| MIACALCIN Nasal Spray can be used safely in patients taking GI and other drugs (eg, aspirin, ibuprofen, NSAIDs) |
|
| MIACALCIN Nasal Spray can be administered concomitantly with calcium and vitamin D supplements |
|
Those with difficulty following daily or weekly dosing instructions
|
| MIACALCIN Nasal Spray has no restrictions on time of administration, food intake, or other medications |
|
| MIACALCIN Nasal Spray is administered with just one spray, once a day |
|
Those with limited mobility
|
| MIACALCIN Nasal Spray has no requirements for remaining upright |
|
| MIACALCIN Nasal Spray has no drug-related venous thromboembolic events |
|
MIACALCIN Nasal Spray is indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause with low bone mass who refuse or cannot tolerate estrogens, or in whom estrogens are contraindicated. Patients should ensure adequate calcium and vitamin D intake.
Rhinitis, other nasal symptoms, back pain, arthralgia, epistaxis, and headache were the most common adverse events. Because calcitonin-salmon is a protein, the potential for a systemic allergic reaction exists. In rare cases, nasal ulcerations were reported that required temporary discontinuation of therapy until healing occurred.
For further information, please consult the complete Prescribing Information.
|
|
|
